Clinical significance of serum procalcitonin in patients with ulcerative colitis

被引:20
|
作者
Koido, Shigeo [1 ]
Ohkusa, Toshifumi [1 ]
Takakura, Kazuki [1 ]
Odahara, Shunichi [1 ]
Tsukinaga, Shintaro [1 ]
Yukawa, Toyokazu [1 ]
Mitobe, Jimi [1 ]
Kajihara, Mikio [1 ]
Uchiyama, Kan [1 ]
Arakawa, Hiroshi [1 ]
Tajiri, Hisao [1 ]
机构
[1] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Kashiwa, Chiba 2778567, Japan
关键词
C-reactive protein; Disease activity; Procalcitonin; Severity; Ulcerative colitis; INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; BACTERIAL-INFECTION; CROHNS-DISEASE; SEPSIS; HYDROCORTISONE; THERAPY; MARKERS;
D O I
10.3748/wjg.v19.i45.8335
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the association of procalcitonin (PCT) with ulcerative colitis (UC) activity. METHODS: Serum PCT levels, C-reactive protein (CRP) levels, the erythrocyte sedimentation rate, and the white blood cell count were analyzed in 18 patients with UC and 11 healthy volunteers. Serum PCT levels were analyzed by an electrochemiluminescence immunoassay. Severity assessments were based on Truelove and Witts' severity index. Correlation of serum PCT and CRP levels with UC activity was examined. Moreover, we assessed serum PCT and CRP levels in patients with a Mayo endoscopic subscore. RESULTS: Serum PCT levels in severe UC patients (n = 7) (0.096 +/- 0.034 ng/mL) were significantly higher than in mild-to-moderate UC patients (n = 11) (0.033 +/- 0.012 ng/mL) and healthy volunteers (n = 11) (0.035 +/- 0.005 ng/mL) (P = 0.0005 and P < 0.0001, respectively). In addition, there was no difference in serum PCT levels between mild-to-moderate UC patients and healthy volunteers. Interestingly, patients with a Mayo endoscopic subscore of 3 points displayed significantly increased levels of serum PCT (0.075 +/- 0.043 ng/mL) compared with patients with a subscore of 2 points (0.03 +/- 0.011 ng/mL) (P = 0.0302). Moreover, CRP levels in patients with severe UC or a Mayo endoscopic subscore of 3 points were not significantly higher than in patients with mild-to-moderate UC or a Mayo endoscopic subscore of 3 points. CONCLUSION: Serum PCT levels were significantly correlated with UC activity. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:8335 / 8341
页数:7
相关论文
共 50 条
  • [41] Serum Interleukin-23 Levels in Patients with Ulcerative Colitis
    Mohammadi, Mojgan
    Hayatbakhsh, Mohammad Mahdi
    Zahedi, Mohammad Javad
    Jalalpour, Mahmood Reza
    Pakgohar, Amin
    IRANIAN JOURNAL OF IMMUNOLOGY, 2011, 8 (03) : 183 - 188
  • [42] Correlations of C-reactive Protein Levels and Erythrocyte Sedimentation Rates with Endoscopic Activity Indices in Patients with Ulcerative Colitis
    Yoon, Jin Young
    Park, Soo Jung
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (04) : 829 - 837
  • [43] The Prevalence and Clinical Significance of Low Procalcitonin Levels Among Patients With Severe Sepsis or Septic Shock in the Emergency Department
    Choe, Eun A.
    Shin, Tae Gun
    Jo, Ik Joon
    Hwang, Sung Yeon
    Lee, Tae Rim
    Cha, Won Chul
    Sim, Min Seob
    SHOCK, 2016, 46 (01): : 37 - 43
  • [44] Fecal Calprotectin and the Clinical Activity Index Are Both Useful to Monitor Medical Treatment in Patients with Ulcerative Colitis
    Burri, Emanuel
    Beglinger, Christoph
    von Felten, Stefanie
    Lehmann, Frank Serge
    DIGESTIVE DISEASES AND SCIENCES, 2015, 60 (02) : 485 - 491
  • [45] Plasma viscosity: a potential predictor of both medical treatment response and clinical stage of ulcerative colitis
    Tolga, Yakar
    Mansur, Cosar Arif
    Savas, Gokturk Huseyin
    Gulhan, Unler Kanat Ayse
    Alper, Parlakgumus
    Ilknur, Kozanoglu
    Ender, Serin
    ANNALI ITALIANI DI CHIRURGIA, 2016, 87 (06) : 531 - 543
  • [46] Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein
    Shimetani, N
    Shimetani, K
    Mori, M
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2004, 64 (05) : 469 - 474
  • [47] Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis
    Koutroubakis, Ioannis E.
    Regueiro, Miguel
    Schoen, Robert E.
    Ramos-Rivers, Claudia
    Hashash, Jana G.
    Schwartz, Marc
    Swoger, Jason
    Barrie, Arthur
    Baidoo, Leonard
    Dunn, Michael A.
    Binion, David G.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (01) : 100 - 105
  • [48] Usefulness of serum procalcitonin levels in pulmonary tuberculosis
    Ugajin, M.
    Miwa, S.
    Shirai, M.
    Ohba, H.
    Eifuku, T.
    Nakamura, H.
    Suda, T.
    Hayakawa, H.
    Chida, K.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 371 - 375
  • [49] Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review
    Demaris, Alix
    Widigson, Ella S. K.
    Ilvemark, Johan F. K. F.
    Steenholdt, Casper
    Seidelin, Jakob B.
    Huisinga, Wilhelm
    Michelet, Robin
    Aulin, Linda B. S.
    Kloft, Charlotte
    PHARMACEUTICS, 2022, 14 (10)
  • [50] Significance of serological markers in the disease course of ulcerative colitis in a prospective clinical cohort of patients
    Kovacs, Gyorgy
    Sipeki, Nora
    Suga, Boglarka
    Tornai, Tamas
    Fechner, Kai
    Norman, Gary L.
    Shums, Zakera
    Antal-Szalmas, Peter
    Papp, Maria
    PLOS ONE, 2018, 13 (03):